Literature DB >> 3817396

Pseudomonas infection of the biliary system resulting from use of a contaminated endoscope.

J I Allen, M O Allen, M M Olson, D N Gerding, C J Shanholtzer, P B Meier, J A Vennes, S E Silvis.   

Abstract

Pseudomonas aeruginosa was present in bile cultures from 10 patients who had undergone previous endoscopic retrograde cholangiopancreatography in 1984. After environmental cultures and review of instrument disinfection, we traced the infections to a single endoscope contaminated with P. aeruginosa, serotype 10. Although the instrument had been cleaned repeatedly with an automatic endoscope cleaning machine, P. aeruginosa survived on residual moisture left in the channels of the endoscope. Contamination ended only after we began to manually suction alcohol through the endoscope before air drying. In 5 of 10 patients, P. aeruginosa caused clinical infections including gangrenous cholecystitis, abscesses, and death. We could identify no factor that distinguished symptomatic from asymptomatic patients. In asymptomatic patients, P. aeruginosa was recovered from gallbladder bile up to 2 mo after endoscopic retrograde cholangiopancreatography. As this P. aeruginosa epidemic was discovered retrospectively because we monitor bile cultures, we advocate this practice as part of endoscopic retrograde cholangiopancreatography procedures.

Entities:  

Mesh:

Year:  1987        PMID: 3817396     DOI: 10.1016/0016-5085(87)90029-1

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  15 in total

1.  Elimination of high titre HIV from fibreoptic endoscopes.

Authors:  C S Neumann
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

Review 2.  Current issues in endoscope reprocessing and infection control during gastrointestinal endoscopy.

Authors:  Douglas B Nelson; Lawrence F Muscarella
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

Review 3.  Duodenoscope-Associated Infections: Update on an Emerging Problem.

Authors:  M Rubayat Rahman; Abhilash Perisetti; Roxana Coman; Pardeep Bansal; Rajiv Chhabra; Hemant Goyal
Journal:  Dig Dis Sci       Date:  2018-12-19       Impact factor: 3.199

Review 4.  Is peracetic acid suitable for the cleaning step of reprocessing flexible endoscopes?

Authors:  Günter Kampf; Patricia M Fliss; Heike Martiny
Journal:  World J Gastrointest Endosc       Date:  2014-09-16

Review 5.  Duodenoscope-associated infections: a review.

Authors:  Gheorghe G Balan; Catalin Victor Sfarti; Stefan Andrei Chiriac; Carol Stanciu; Anca Trifan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-09-03       Impact factor: 3.267

6.  A Novel Protocol Obviates Endoscope Sampling for Carbapenem-Resistant Enterobacteriaceae: Experience of a Center with a Prior Outbreak.

Authors:  Zachary L Smith; Arshish Dua; Kia Saeian; Nathan A Ledeboer; Mary Beth Graham; Murad Aburajab; Darren D Ballard; Abdul H Khan; Kulwinder S Dua
Journal:  Dig Dis Sci       Date:  2017-07-05       Impact factor: 3.199

7.  Diagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis.

Authors:  M Oezcueruemez-Porsch; D Kunz; P D Hardt; T Fadgyas; O Kress; H U Schulz; H Schnell-Kretschmer; H Temme; S Westphal; C Luley; H U Kloer
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

8.  Emphysematous cholecystitis after ERCP.

Authors:  C Alvarez; K Hunt; S W Ashley; H A Reber
Journal:  Dig Dis Sci       Date:  1994-08       Impact factor: 3.199

Review 9.  Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy.

Authors:  Julia Kovaleva; Frans T M Peters; Henny C van der Mei; John E Degener
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

10.  Bactericidal, virucidal, and mycobactericidal activities of reused alkaline glutaraldehyde in an endoscopy unit.

Authors:  J N Mbithi; V S Springthorpe; S A Sattar; M Pacquette
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.